The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK a (Q44443448)
Jump to navigation
Jump to search
scientific article published on May 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK a |
scientific article published on May 1, 2003 |
Statements
1 reference
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK a (English)
1 reference
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921) (English)
1 reference
1 reference
M. Oosterveld
S. Suciu
G. Verhoef
B. Labar
A. Belhabri
C. Aul
D. Selleslag
A. Ferrant
P. Wijermans
F. Mandelli
S. Amadori
U. Jehn
P. Muus
R. Zittoun
U. Hess
O. Anak
F. Beeldens
R. Willemze
1 May 2003
1 reference
1 reference
1 reference
17
1 reference
5
1 reference
859-868
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference